Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View

被引:29
作者
Alfano, Daniela [1 ]
Franco, Paola [1 ]
Stoppelli, Maria Patrizia [1 ]
机构
[1] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy
关键词
urokinase receptor; cell migration; epithelial mesenchyme transition; stemness; cell differentiation; virus infection; PLASMINOGEN-ACTIVATOR RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; VITRONECTIN-BINDING SITE; AMINO-TERMINAL FRAGMENT; SOMATOMEDIN B-DOMAIN; SMOOTH-MUSCLE-CELLS; IN-VIVO; DOWN-REGULATION; CATHEPSIN-B; LIPID RAFTS;
D O I
10.3389/fcell.2022.818616
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Urokinase-type plasminogen activator receptor (uPAR or CD87) is a glycosyl-phosphatidyl-inositol anchored (GPI) membrane protein. The uPAR primary ligand is the serine protease urokinase (uPA), converting plasminogen into plasmin, a broad spectrum protease, active on most extracellular matrix components. Besides uPA, the uPAR binds specifically also to the matrix protein vitronectin and, therefore, is regarded also as an adhesion receptor. Complex formation of the uPAR with diverse transmembrane proteins, including integrins, formyl peptide receptors, G protein-coupled receptors and epidermal growth factor receptor results in intracellular signalling. Thus, the uPAR is a multifunctional receptor coordinating surface-associated pericellular proteolysis and signal transduction, thereby affecting physiological and pathological mechanisms. The uPAR-initiated signalling leads to remarkable cellular effects, that include increased cell migration, adhesion, survival, proliferation and invasion. Although this is beyond the scope of this review, the uPA/uPAR system is of great interest to cancer research, as it is associated to aggressive cancers and poor patient survival. Increasing evidence links the uPA/uPAR axis to epithelial to mesenchymal transition, a highly dynamic process, by which epithelial cells can convert into a mesenchymal phenotype. Furthermore, many reports indicate that the uPAR is involved in the maintenance of the stem-like phenotype and in the differentiation process of different cell types. Moreover, the levels of anchor-less, soluble form of uPAR, respond to a variety of inflammatory stimuli, including tumorigenesis and viral infections. Finally, the role of uPAR in virus infection has received increasing attention, in view of the Covid-19 pandemics and new information is becoming available. In this review, we provide a mechanistic perspective, via the detailed examination of consolidated and recent studies on the cellular responses to the multiple uPAR activities.
引用
收藏
页数:20
相关论文
共 236 条
[51]   Urokinase links plasminogen activation and cell adhesion by cleavage of the RGD motif in vitronectin [J].
De Lorenzi, Valentina ;
Ferraris, Gian Maria Sarra ;
Madsen, Jeppe B. ;
Lupia, Michela ;
Andreasen, Peter A. ;
Sidenius, Nicolai .
EMBO REPORTS, 2016, 17 (07) :982-998
[52]   Urokinase induces basophil chemotaxis through a urokinase receptor or epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2 [J].
de Paulis, A ;
Montuori, N ;
Prevete, N ;
Fiorentino, I ;
Rossi, FW ;
Visconte, V ;
Rossi, G ;
Marone, G ;
Ragno, P .
JOURNAL OF IMMUNOLOGY, 2004, 173 (09) :5739-5748
[53]   Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGFs/IGF-1R axis [J].
De Vincenzo, Anna ;
Belli, Stefania ;
Franco, Paola ;
Telesca, Marialucia ;
Iaccarino, Ingram ;
Botti, Gerardo ;
Carriero, Maria, V ;
Ranson, Marie ;
Stoppelli, Maria Patrizia .
INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (10) :2827-2839
[54]   Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity - Generation of a new integrin inhibitor [J].
Degryse, B ;
Resnati, M ;
Czekay, RP ;
Loskutoff, DJ ;
Blasi, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (26) :24792-24803
[55]   Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin [J].
Deng, G ;
Royle, G ;
Wang, S ;
Crain, K ;
Loskutoff, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12716-12723
[56]   Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin [J].
Deng, G ;
Curriden, SA ;
Hu, G ;
Czekay, RP ;
Loskutoff, DJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 189 (01) :23-33
[57]   Integrins in cancer: biological implications and therapeutic opportunities [J].
Desgrosellier, Jay S. ;
Cheresh, David A. .
NATURE REVIEWS CANCER, 2010, 10 (01) :9-22
[58]   New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer [J].
Dongre, Anushka ;
Weinberg, Robert A. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2019, 20 (02) :69-84
[59]   Semiautomatic Landmark-Based Two-Dimensional-Three-Dimensional Image Fusion in Living Mice: Correlation of Near-Infrared Fluorescence Imaging of Cy5.5-Labeled Antibodies with Flat-Panel Volume Computed Tomography [J].
Dullin, Christian ;
Zientkowska, Marta ;
Napp, Joanna ;
Missbach-Guentner, Jeannine ;
Krell, Hans-Willi ;
Mueller, Friedernann ;
Grabbe, Eckhardt ;
Tietze, Lutz-F. ;
Alves, Frauke .
MOLECULAR IMAGING, 2009, 8 (01) :2-14
[60]   Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays [J].
Eckstein, Markus ;
Sailer, Verena ;
Nielsen, Boye Schnack ;
Wittenberg, Thomas ;
Wiesmann, Veit ;
Lieb, Verena ;
Nolte, Elke ;
Hartmann, Arndt ;
Kristiansen, Glen ;
Wernert, Nicolas ;
Wullich, Bernd ;
Taubert, Helge ;
Wach, Sven .
LABORATORY INVESTIGATION, 2019, 99 (10) :1527-1534